Home LiteratureArticle Details
PMID: 15085186 Published · ppublish English Journal Article Review

West Nile virus: a growing concern?

The Journal of clinical investigation ·Vol. 113 ·No. 8 ·2004-04-00 ·Pages 1102-7

Gould LH, Fikrig E

Abstract

West Nile virus was first detected in North America in 1999 and has subsequently spread throughout the United States and Canada and into Mexico and the Caribbean. This review describes the epidemiology and ecology of West Nile virus in North America and the prospects for effective treatments and vaccines.

MeSH Terms
Animals Ecology Humans Viral Vaccines/immunology West Nile Fever/epidemiology,therapy,transmission West Nile virus/genetics,growth & development
Chemicals
Viral Vaccines
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Gould L Hannah
Department of Epidemiology and Public Health and Section of Rheumatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Fikrig Erol
References (79)
79 references, click to expand
  1. Experimental infection of North American birds with the New York 1999 strain of West Nile virus.
    Emerg Infect Dis. 2003 Mar;9(3):311-22 PMID: 12643825
  2. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases.
    Emerg Infect Dis. 2003 Mar;9(3):376-9 PMID: 12643836
  3. Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States.
    Virology. 2003 May 10;309(2):190-5 PMID: 12758166
  4. Transmission of West Nile virus from an organ donor to four transplant recipients.
    N Engl J Med. 2003 May 29;348(22):2196-203 PMID: 12773646
  5. Potential North American vectors of West Nile virus.
    Ann N Y Acad Sci. 2001 Dec;951:317-24 PMID: 11797788
  6. Experimental infection of horses with West Nile virus and their potential to infect mosquitoes and serve as amplifying hosts.
    Ann N Y Acad Sci. 2001 Dec;951:338-9 PMID: 11797793
  7. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis.
    Emerg Infect Dis. 2002 Mar;8(3):245-51 PMID: 11927020
  8. West Nile Virus activity--United States, 2001.
    MMWR Morb Mortal Wkly Rep. 2002 Jun 14;51(23):497-501 PMID: 12079245
  9. Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines.
    Am J Trop Med Hyg. 2002 Feb;66(2):115-6 PMID: 12135278
  10. West Nile virus: a primer for the clinician.
    Ann Intern Med. 2002 Aug 6;137(3):173-9 PMID: 12160365
  11. West Nile virus.
    Lancet Infect Dis. 2002 Sep;2(9):519-29 PMID: 12206968
  12. Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002.
    MMWR Morb Mortal Wkly Rep. 2002 Oct 4;51(39):877-8 PMID: 12375687
  13. Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis.
    Transpl Infect Dis. 2002 Sep;4(3):160-2 PMID: 12421462
  14. West Nile virus vaccine.
    Curr Drug Targets Infect Disord. 2001 May;1(1):37-50 PMID: 12455232
  15. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model.
    Emerg Infect Dis. 2002 Dec;8(12):1392-7 PMID: 12498653
  16. Human immunoglobulin as a treatment for West Nile virus infection.
    J Infect Dis. 2003 Jul 1;188(1):1-4 PMID: 12825164
  17. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.
    J Infect Dis. 2003 Jul 1;188(1):5-12 PMID: 12825165
  18. Neurologic manifestations and outcome of West Nile virus infection.
    JAMA. 2003 Jul 23;290(4):511-5 PMID: 12876094
  19. West Nile virus.
    JAMA. 2003 Jul 23;290(4):524-8 PMID: 12876096
  20. West Nile virus in farmed alligators.
    Emerg Infect Dis. 2003 Jul;9(7):794-9 PMID: 12890319
  21. Serologic evidence of West Nile virus infection in horses, Yucatan State, Mexico.
    Emerg Infect Dis. 2003 Jul;9(7):857-9 PMID: 12890328
  22. Serologic evidence of West Nile virus transmission, Jamaica, West Indies.
    Emerg Infect Dis. 2003 Jul;9(7):860-3 PMID: 12890329
  23. West Nile virus infection in crocodiles.
    Emerg Infect Dis. 2003 Jul;9(7):887-9 PMID: 12899140
  24. Detection of West Nile virus in blood donations--United States, 2003.
    MMWR Morb Mortal Wkly Rep. 2003 Aug 15;52(32):769-72 PMID: 12917583
  25. IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection.
    J Immunol. 2003 Sep 1;171(5):2524-31 PMID: 12928402
  26. DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus.
    Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10460-4 PMID: 12917491
  27. The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis.
    Clin Infect Dis. 2003 Sep 15;37(6):e88-90 PMID: 12955669
  28. Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination.
    J Clin Microbiol. 2003 Sep;41(9):4217-23 PMID: 12958248
  29. Update: Detection of West Nile virus in blood donations--United States, 2003.
    MMWR Morb Mortal Wkly Rep. 2003 Sep 26;52(38):916-9 PMID: 14515874
  30. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.
    Virology. 2003 Sep 15;314(1):190-5 PMID: 14517072
  31. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut.
    Science. 1999 Dec 17;286(5448):2331-3 PMID: 10600741
  32. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.
    Science. 1999 Dec 17;286(5448):2333-7 PMID: 10600742
  33. Genetic analysis of West Nile New York 1999 encephalitis virus.
    Lancet. 1999 Dec 4;354(9194):1971-2 PMID: 10622305
  34. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.
    J Infect Dis. 2000 Oct;182(4):1214-7 PMID: 10979920
  35. Update: West Nile Virus activity--Eastern United States, 2000.
    MMWR Morb Mortal Wkly Rep. 2000 Nov 24;49(46):1044-7 PMID: 11105767
  36. A live attenuated West Nile virus strain as a potential veterinary vaccine.
    Viral Immunol. 2000;13(4):401-10 PMID: 11192286
  37. Pathogenicity of West Nile virus for turkeys.
    Avian Dis. 2000 Oct-Dec;44(4):932-7 PMID: 11195649
  38. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.
    J Virol. 2001 May;75(9):4040-7 PMID: 11287553
  39. The outbreak of West Nile virus infection in the New York City area in 1999.
    N Engl J Med. 2001 Jun 14;344(24):1807-14 PMID: 11407341
  40. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey.
    Lancet. 2001 Jul 28;358(9278):261-4 PMID: 11498211
  41. Yellow fever vector live-virus vaccines: West Nile virus vaccine development.
    Trends Mol Med. 2001 Aug;7(8):350-4 PMID: 11516995
  42. Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999).
    J Infect Dis. 2001 Oct 1;184(7):809-16 PMID: 11550123
  43. Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
    Emerg Infect Dis. 2001 Jul-Aug;7(4):759 PMID: 11585547
  44. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000.
    Emerg Infect Dis. 2001 Jul-Aug;7(4):654-8 PMID: 11589170
  45. West Nile encephalitis: an emerging disease in the United States.
    Clin Infect Dis. 2001 Nov 15;33(10):1713-9 PMID: 11595987
  46. Immunization of mice against West Nile virus with recombinant envelope protein.
    J Immunol. 2001 Nov 1;167(9):5273-7 PMID: 11673542
  47. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro.
    Emerg Infect Dis. 2002 Jan;8(1):107-8 PMID: 11749765
  48. The ecology of West Nile virus in South Africa and the occurrence of outbreaks in humans.
    Ann N Y Acad Sci. 2001 Dec;951:143-52 PMID: 11797772
  49. Antibody prophylaxis and therapy for flavivirus encephalitis infections.
    Ann N Y Acad Sci. 2001 Dec;951:286-97 PMID: 11797785
  50. Provisional surveillance summary of the West Nile virus epidemic--United States, January-November 2002.
    MMWR Morb Mortal Wkly Rep. 2002 Dec 20;51(50):1129-33 PMID: 12537287
  51. Laboratory-acquired West Nile virus infections--United States, 2002.
    MMWR Morb Mortal Wkly Rep. 2002 Dec 20;51(50):1133-5 PMID: 12537288
  52. Intrauterine West Nile virus infection--New York, 2002.
    MMWR Morb Mortal Wkly Rep. 2002 Dec 20;51(50):1135-6 PMID: 12537289
  53. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.
    J Virol. 2003 Feb;77(4):2578-86 PMID: 12551996
  54. Direct (non-vector) transmission of West Nile virus in geese.
    Avian Pathol. 2003 Oct;32(5):489-94 PMID: 14522704
  55. West Nile virus infection among turkey breeder farm workers--Wisconsin, 2002.
    MMWR Morb Mortal Wkly Rep. 2003 Oct 24;52(42):1017-9 PMID: 14574276
  56. Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice.
    Vaccine. 2003 Nov 7;21(31):4514-8 PMID: 14575761
  57. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus.
    Viral Immunol. 2003;16(3):259-78 PMID: 14583143
  58. West Nile virus transmission in resident birds, Dominican Republic.
    Emerg Infect Dis. 2003 Oct;9(10):1299-302 PMID: 14609467
  59. Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice.
    J Virol. 2003 Dec;77(24):12941-9 PMID: 14645550
  60. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis.
    J Virol. 2003 Dec;77(24):13323-34 PMID: 14645588
  61. West Nile virus activity--United States, November 20-25, 2003.
    MMWR Morb Mortal Wkly Rep. 2003 Nov 28;52(47):1160 PMID: 14647020
  62. Equine vaccine for West Nile virus.
    Dev Biol (Basel). 2003;114:221-7 PMID: 14677692
  63. Transstadial transfer of West Nile virus by three species of ixodid ticks (Acari: Ixodidae).
    J Med Entomol. 2003 Jul;40(4):528-33 PMID: 14680122
  64. West Nile virus: epidemiology and ecology in North America.
    Adv Virus Res. 2003;61:185-234 PMID: 14714433
  65. Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay.
    J Clin Microbiol. 2004 Jan;42(1):65-72 PMID: 14715733
  66. Serologic evidence of West Nile virus infection in black bears (Ursus americanus) from New Jersey.
    J Wildl Dis. 2003 Oct;39(4):894-6 PMID: 14733286
  67. Community-acquired West Nile virus infection in solid-organ transplant recipients.
    Transplantation. 2004 Feb 15;77(3):399-402 PMID: 14966414
  68. West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death.
    Transplantation. 2004 Feb 15;77(3):466-9 PMID: 14966429
  69. West Nile virus, Guadeloupe.
    Emerg Infect Dis. 2004 Apr;10(4):706-8 PMID: 15200864
  70. Transplacental infection with Japanese encephalitis virus.
    J Infect Dis. 1980 Jun;141(6):712-5 PMID: 6248601
  71. Susceptibility of dogs to West Nile virus: a survey and pathogenicity trial.
    J Comp Pathol. 1989 Jan;100(1):59-66 PMID: 2537346
  72. West Nile virus (Flaviviridae:Flavivirus) in experimentally infected Argas ticks (Acari:Argasidae).
    Am J Trop Med Hyg. 1993 May;48(5):726-37 PMID: 8517492
  73. Antibody-dependent enhancement of infection and the pathogenesis of viral disease.
    Clin Infect Dis. 1994 Sep;19(3):500-12 PMID: 7811870
  74. Vertical transmission of dengue.
    Clin Infect Dis. 1997 Dec;25(6):1374-7 PMID: 9431381
  75. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes.
    J Virol. 1998 Jun;72(6):4925-30 PMID: 9573260
  76. West Nile encephalitis epidemic in southeastern Romania.
    Lancet. 1998 Sep 5;352(9130):767-71 PMID: 9737281
  77. West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness.
    J Gen Virol. 1998 Oct;79 ( Pt 10):2375-80 PMID: 9780042
  78. Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis.
    Lancet. 1999 Oct 9;354(9186):1261-2 PMID: 10520637
  79. Induced virus infections in man by the Egypt isolates of West Nile virus.
    Am J Trop Med Hyg. 1954 Jan;3(1):19-50 PMID: 13114588
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
DOI
10.1172/JCI21623
Published
2004-04-00
Pages
1102-7
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC385414
Subset
IM
External Links
PubMed source DOI: 10.1172/JCI21623 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2